Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
Novo Nordisk recently made headlines petitioning FDA to stop the compounding of its blockbuster GLP-1 products so it can sell its patented ...
Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...
Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...
The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...
The results of the small study add to evidence that people find drugs like Ozempic and Wegovy helpful to manage cravings for ...
On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The situation is causing the FDA regulatory headaches and, more seriously, posing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results